Galecto Biotech Ab is a biotechnology company based in Copenhagen, Denmark, focused on developing innovative therapies for fibrotic diseases and cancer. The company specializes in the research and development of small molecule drugs that target galectin proteins, which play a crucial role in various pathological processes, including inflammation and tissue remodeling. Through its advanced scientific approach, Galecto aims to address significant unmet medical needs and improve patient outcomes in challenging therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

28 Patents

#15 in Copenhagen

#112 in Denmark

#23,299 in the World

Copenhagen, Denmark

Galecto Biotech Ab

Forward Citations = 75

19 inventors:

Ulf Nilsson (17 out of 21 patents)

Fredrik Zetterberg (17 out of 17 patents)

Hakon Leffler (15 out of 17 patents)

4. Thomas Brimert (7 out of 10 patents)

5. Richard Johnsson (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galecto Biotech Ab. Retrieved from https://idiyas.com/company/galecto-biotech-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

11 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]